AdvanSix

Piper Sandler Upgrades ADVANSIX Rating to Overweight

ADVANSIX INC : PIPER SANDLER RAISES TO OVERWEIGHT FROM NEUTRAL; RAISES TARGET PRICE TO $32 FROM $26

Piper Sandler upgraded AdvanSix's rating from Neutral to Overweight, adjusting the target price from $26.00 to $32.00. AdvanSix Inc. is a comprehensive manufacturer primarily producing Nylon 6, polymer resins, and fertilizers, widely used in the automotive, electronics, and textile industries. The company operates in the United States and expands its business internationally, with the main revenue source coming from the U.S. market

Piper Sandler: Upgrades AdvanSix Rating

Wall Street analysts have revised ratings and price targets for several U.S.-listed companies. Advansix was upgraded to overweight by Piper Sandler, raising its target price to $32. Cognizant also received an upgrade from JP Morgan, with a new target of $98. In contrast, Eli Lilly's target was cut to $675 by HSBC, while Inozyme Pharma was downgraded to neutral by Piper Sandler, with a target price reduced to $4. Other notable changes include target increases for KLA Corp and Lam Research.

Piper Sandler Upgrades ADVANSIX Rating to Overweight

Summary

Impact Analysis